Safety and Efficacy of Everolimus Treatment in Liver Transplantation for Liver Cancer
Safety and Efficacy of Everolimus Treatment in Liver Transplantation for Liver Cancer
Enrolling by invitation · NCT02081755 · Registry updated 2026-01-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Efficacy of Everolimus Treatment in Liver Transplantation for Liver Cancer | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Enrolling by invitation | Phase 4 | 2026-01-27 | NCT02081755 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Baylor Research Institute | 66 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Baylor University Medical Center | Dallas | United States | 87 |
| Mayo Clinic | Rochester | United States | 664 |
| Mount Sinai Medical Center | New York | United States | 40 |
| Northwestern University School of Medicine | Chicago | United States | 1 |
| University of California at San Francisco | San Francisco | United States | 12 |
| University of Kansas Medical Center | Kansas City | United States | 240 |
| University of Pennsylvania | Philadelphia | United States | 507 |
| University of Tennessee- Methodist University Hospital | Memphis | United States | 1 |
| Washington University School of Medicine | St Louis | United States | 895 |